DUALITYBIO-B(09606) recommends adopting the 2025 stock plan.

DUALITYBIO-B (09606) issued an announcement on December 13, 2025, stating that the board of directors of Imeon Biotech (the Company, together with its subsidiaries referred to as the Group) has proposed the adoption of the 2025 Stock Plan. However, it must be approved by the Company's shareholders before it can be implemented. The 2025 Stock Plan aims to attract and retain individuals who have made significant contributions to the long-term development and success of the Group, to recognize and reward their past contributions to the Group, to provide them with the opportunity to acquire proprietary interests in the Company, and to encourage them to further contribute to the company's success, thus enhancing the value of the Company and its shares for the benefit of the Company and all its shareholders. The 2025 Stock Plan will provide the Company with a flexible way to retain, motivate, reward, compensate, and provide benefits to participants.